ArticleThe Journal of clinical investigation2010

Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice.

Dhanalakshmi Chinnasamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.